Clinical Trials In Minneapolis

Discover hundreds of clinical trials in Minneapolis.
Search clinical trials in Minneapolis by condition or phase.

e.g. Respiratory Diseases

Minneapolis•Healthy volunteers: No

Filter results

Results: 1,050

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Recruiting

Sponsor:

NIH

Location:

Minneapolis, Los Angeles, Salt Lake City

Code:

NCT01543620

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Minneapolis, Rochester, Dothan, Phoenixshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

Phase 2

Phase 3

Sponsor:

Regeneron Pharmaceuticals

Location:

Rochester, Plymouth, Phoenix, Apple Valleyshow 40 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Recruiting

Phase 3

Sponsor:

Novo Nordisk A/S

Location:

Minneapolis, Escondido, New Haven, Columbusshow 17 more

Code:

NCT05726227

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Semaglutide

Placebo

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

Phase 3

Sponsor:

Sanofi

Location:

Plymouth, Birmingham, Cullman, Phoenixshow 61 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations

Recruiting

Phase 3

Sponsor:

Palvella Therapeutics, Inc.

Location:

Rochester, New Brighton, Palo Alto, New Yorkshow 6 more

Code:

NCT06239480

Conditions

Microcystic Lymphatic Malformation

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

QTORIN 3.9% Rapamycin Anhydrous Gel

Veterans Coordinated Community Care (3C) Study

Recruiting

Sponsor:

Brown University

Location:

Minneapolis, Little Rock, Boston, Saint Louisshow 3 more

Code:

NCT05272176

Conditions

Suicide

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Coping Long Term with Active Suicide Program (CLASP)

Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

Recruiting

Phase 3

Sponsor:

Keryx Biopharmaceuticals

Location:

Minneapolis, Birmingham, Phoenix, San Franciscoshow 9 more

Code:

NCT04523727

Conditions

Hyperphosphatemia Related to Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 6 - 16

Healthy Volunteers: Not accepted

Interventions

ferric citrate

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Minneapolis, Woodbury, Waconia, Sartellshow 941 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Recruiting

Phase 2

Sponsor:

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Location:

Minneapolis, Torrance, Brandon, Miamishow 4 more

Code:

NCT05540327

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

M5049 low dose

M5049 medium dose

M5049 high dose

Placebo

M5049 very high dose

e.g. Respiratory Diseases

Minneapolis•Healthy volunteers: No

Filter results

Results: 1,050

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Recruiting

Sponsor:

NIH

Location:

Minneapolis, Los Angeles, Salt Lake City

Code:

NCT01543620

Conditions

Cystic Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Minneapolis, Rochester, Dothan, Phoenixshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting

Phase 2

Phase 3

Sponsor:

Regeneron Pharmaceuticals

Location:

Rochester, Plymouth, Phoenix, Apple Valleyshow 40 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Recruiting

Phase 3

Sponsor:

Novo Nordisk A/S

Location:

Minneapolis, Escondido, New Haven, Columbusshow 17 more

Code:

NCT05726227

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Semaglutide

Placebo

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

Phase 3

Sponsor:

Sanofi

Location:

Plymouth, Birmingham, Cullman, Phoenixshow 61 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations

Recruiting

Phase 3

Sponsor:

Palvella Therapeutics, Inc.

Location:

Rochester, New Brighton, Palo Alto, New Yorkshow 6 more

Code:

NCT06239480

Conditions

Microcystic Lymphatic Malformation

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

QTORIN 3.9% Rapamycin Anhydrous Gel

Veterans Coordinated Community Care (3C) Study

Recruiting

Sponsor:

Brown University

Location:

Minneapolis, Little Rock, Boston, Saint Louisshow 3 more

Code:

NCT05272176

Conditions

Suicide

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Coping Long Term with Active Suicide Program (CLASP)

Study to Evaluate the Safety and Tolerability of Ferric Citrate in Children With Hyperphosphatemia Related to Chronic Kidney Disease

Recruiting

Phase 3

Sponsor:

Keryx Biopharmaceuticals

Location:

Minneapolis, Birmingham, Phoenix, San Franciscoshow 9 more

Code:

NCT04523727

Conditions

Hyperphosphatemia Related to Chronic Kidney Disease

Eligibility Criteria

Sex: All

Age: 6 - 16

Healthy Volunteers: Not accepted

Interventions

ferric citrate

MILD® Percutaneous Image-Guided Lumbar Decompression: a Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Minneapolis, Woodbury, Waconia, Sartellshow 941 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

Interspinous Process Decompression

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Recruiting

Phase 2

Sponsor:

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Location:

Minneapolis, Torrance, Brandon, Miamishow 4 more

Code:

NCT05540327

Conditions

Systemic Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

M5049 low dose

M5049 medium dose

M5049 high dose

Placebo

M5049 very high dose